Gosset AKESOgen General Information
AKESOgen was an Atlanta-based contract research organization specializing in biomarker discovery, genomics, pharmacogenomics, and biobanking for academic institutions, pharmaceutical companies, biotechnology firms and government agencies. The company provided clinical trial support through genomic analysis and established/validated biomarkers for precision medicine applications. In December 2019 it was acquired by Tempus to expand their capabilities beyond oncology into broader disease areas. AKESOgen specialized in providing high-quality genomic data generation—including next-gen sequencing/genotyping/expression/methylation—for research scientists across pharma/life sciences/government sectors before its acquisition by Tempus in late December 2019.
Contact Information
United States
Drug Pipeline
No pipeline data available
Key Partnerships
CDC (Centers for Disease Control and Prevention), U.S. Department of Veterans Affairs, American Cancer Society, Kaiser Permanente
AKESOgen Funding
No funding data available